Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Mitochondrial Genome Sequencing and Depletion/Integrity Panel Molecular Genetics Laboratory London Health Sciences Centre Canada | 47 | 52 |
|
OPA3 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 2 | 1 |
|
OPA3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Rhabdomyolysis and Metabolic Myopathy Panel Invitae United States | 202 | 128 |
|
Invitae Nuclear Mitochondrial Disorders Panel Invitae United States | 394 | 319 |
|
Mitochondrial Disorders Panel (Nuclear Genes Only) PreventionGenetics United States | 290 | 251 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Invitae Comprehensive Carrier Screen without X-linked Disorders Invitae United States | 228 | 279 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 247 | 301 |
|
Costeff Optic Atrophy Syndrome Myriad Genetics, Inc. United States | 1 | 1 |
|
OPA3 - 3-Methylglutaconic aciduria Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 1 | 1 |
|
Anterior Segment Dysgenesis Disorders Panel PreventionGenetics United States | 270 | 276 |
|
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel PreventionGenetics United States | 106 | 83 |
|
Invitae Metabolic Newborn Screening Confirmation Panel Invitae United States | 201 | 158 |
|
Invitae United States | 17 | 15 |
|
Invitae Organic Acidemias Panel Invitae United States | 108 | 97 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Invitae United States | 353 | 208 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.